TIP, a T-cell factor identified using high-throughput screening increases survival in a graft-versus-host disease model

Nature Biotechnology

Volumn 21, Issue 3, 2003, Pages 302-307

  Fiscella, Michele ^a   Perry, James W ^a   Teng, Baiqin ^a   Bloom, Michael ^a   Zhang, Chen ^a   Leung, Kam ^a   Pukac, Laurie ^a   Florence, Kimberly ^a   Concepcion, Alice ^a   Liu, Binjun ^a   Meng, Ying ^a   Chen, Cecil ^a   Elgin, Erika Cochrane ^a   Kanakaraj, Palanisamy ^a   Kaufmann, Thomas E ^a   Porter, Joelle ^a   Cibotti, Ricardo ^a   Mei, Yun ^a   Zhou, Joe ^a   Chen, Guoxian ^a   Roschke, Viktor ^a   Komatsoulis, George ^a   Mansfield, Brian ^a   Ruben, Steve ^a   Sanyal, Indra ^a   Migone, Thi Sau ^a   more..

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; BIOLOGICAL MEMBRANES; CELLS; PROTEINS;

SCREENING ASSAYS;

BIOTECHNOLOGY;

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BIOASSAY; BIOINFORMATICS; CELL LINE; CONTROLLED STUDY; GENE LIBRARY; GENETIC CODE; GENOMICS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VIVO STUDY; MEMBRANE POTENTIAL; MODEL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; SCREENING; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; HUMANS; KIDNEY; MICE; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, PROTEIN; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES; TRANSFECTION;

ANIMALIA; MAMMALIA; MURINAE;

EID: 0037338366     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt797     Document Type: Article

References (19)

1. st century. Curr. Opin. Chem. Biol. 4, 445-451 (2000).
2. Fox, S., Farr-Jones, S. & Yund, M.A. High-throughput screening for drug discovery: continually transitioning into new technology. J. Biomol. Screen. 4, 183-186 (1999).
3. Eddy, S.R. Profile hidden Markov models. Bioinformatics 14, 755-763 (1998).
4. Nielsen, H., Engelbrecht, J., Brunak, S. & von Heijne, G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10, 1-6 (1997).
5. Barash, S., Wei, W., & Shi, Y. Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. Biochem. Biophys. Res. Commun. 224, 835-842 (2002).
6. Chen, C. et al. An integral functional genomics screening program reveals novel a role for BMP-9 in glucose homeostasis. Nat. Biotechnol. 21, 294-301 (2003).
7. Swartzman, E.E., Miraglia, S.J., Mellentin-Michelott, J., Evangelista, L. & Yuan, P.M. Homogeneous cell- and bead-based assays for high-throughput screening using fluorometric microvolume assay technology. J. Biomol. Screen. 4, 193-204 (1999).
8. Gurlo, T., Huang, W.-W. & von Grafstein, H. PGE2 inhibits IL-2- and IL-4-dependent proliferation of CTLL-2 and HT2 cells. Cytokine 10, 265-274 (1998).
9. Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T-cell activation. Nat. Immunol. 2, 261-268 (2001).
10. Tseng, S.Y. et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193, 839-846 (2001).
11. Freeman, G.J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034 (2000).
12. Yang, Y.G., Dey, B.R., Sergio, J.J., Perason, D.A. & Sykes, M. Donor-derived interferon-γ is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 102, 2126-2135 (1998).
13. Cho, C.Q., Wittmer, S. & Dalton, D.K. Failure to suppress the expansion of the activated CD4 T-cell population in interferon-γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123-128 (2000).
14. Brok, H.P., Vossen, J.M. & Heidt, P.J. IFN-γ-mediated prevention of graft-versushost-disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells. Bone Marrow Transplant. 22, 1005-1010 (1998).
15. Holler, E. et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 25, 237-241 (2000).
16. LaFleur, D.W. et al. Interferon-κ, a novel type I interferon expressed in human keratinocytes. J. Biol. Chem. 276, 39765-39771 (2001).
17. Forrer, P., Tamaskovic, R. & Jaussi, R. Enzyme-linked immunosorbent assay for measurement of JNK, ERK, and p38 kinase activities. Biol. Chem. 379, 1101-1110 (1998).
18. Kotanides, H. & Reich, N.C. Requirement of tyrosine phosphorylation for rapid activation of DNA binding factor by IL-4. Science 262, 1265-1267 (1993).
19. Gleichmann, E., Pals, S.T., Rolink, A.G., Radaszkiewicz, T. & Gleichmann, H. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological disease. Immunol. Today 5, 324-332 (1984).